Taysha Gene Therapies, Inc. TSHA Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s other income, net (note 6)?
- Taysha Gene Therapies, Inc. (TSHA) reported other income, net (note 6) of -$31K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s other income, net (note 6) changed year-over-year?
- Taysha Gene Therapies, Inc.'s other income, net (note 6) decreased by 338.5% year-over-year, from $13K to -$31K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other income, net (note 6)?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s other income, net (note 6) has grown at a 152.9% compound annual growth rate (CAGR), from -$18K to -$291K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.